Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related GEVA
16 Biotech Catalysts SunTrust Is Tracking
US Stock Futures Surge Ahead Of Economic Data
Related
Ferrellgas, Prothena Lead Friday's After-Hours Movers
What's Going On With Prothena Corporation?
What's in Store for Prothena (PRTA) this Earnings Season? - Analyst Blog (Zacks)

Goldman Sachs initiated coverage on shares of Synageva BioPharma (NASDAQ: GEVA) with a “buy” rating. The target price for Synageva BioPharma is set to $72. Synageva BioPharma's shares closed at $52.61 yesterday.

Bank of America initiated coverage on shares of Prothena (NASDAQ: PRTA) with a “neutral” rating. The target price for Prothena is set to $28. Prothena's shares closed at $27.09 yesterday.

Analysts at Mizuho Securities initiated coverage on shares of Abercrombie & Fitch Company (NYSE: ANF) with a “neutral” rating. Abercrombie & Fitch's shares closed at $35.16 yesterday.

Analysts at DA Davidson initiated coverage on shares of Exterran Holdings (NYSE: EXH) with a “neutral” rating. The target price for Exterran Holdings is set to $35. Exterran's shares closed at $32.78 yesterday.

Latest Ratings for GEVA

DateFirmActionFromTo
Mar 2015JP MorganDowngradesOverweightNeutral
Feb 2015CitigroupMaintainsNeutral
Oct 2014SunTrust Robinson HumphreyInitiates Coverage onBuy

View More Analyst Ratings for GEVA
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (ANF + EXH)

Around the Web, We're Loving...